Bangalore, India, Saratoga, Calif. and Adelaide, Australia, April 20 /PRNewswire/ – Former Secretary of the Government of India’s Department of Biotechnology and distinguished biotechnologist joins the Global Advisory Board to provide strategic guidance for Bugworks Research’s portfolio of projects.
Bugworks Research, a clinical-stage biopharmaceutical company, has Dr. Renu Swarup won as an honorary member of the Global Advisory Board. dr medical Swarup is the former Secretary of the Government of India’s Department of Biotechnology and brings over three decades of experience in the biotech sector.
As a member and secretary of the Expert Committee, Dr. Swarup oversaw the preparation of the Biotechnology Vision in 2001, the National Biotechnology Development Strategy in 2007 and Strategy II in 2015-20. She was Founding Executive Director of the Biotechnology Industry Research Assistance Council (BIRAC), a public sector firm with a particular focus on supporting start-ups and SMEs. By strengthening biotechnology translational research and through industry-academic partnerships, it has supported over 5000 start-ups and nearly 500 small companies to pursue innovative research and product development. She is a member of the National Academy of Sciences, India (NASI)). As a member of the Prime Minister’s Scientific Advisory Committee on Women in Science, she has been an active advocate for women scientists and is a member of the Third World Organization for Women in Science. She played a crucial role in DBT’s response to develop technological solutions to combat COVID-19 in India.
dr Anand Anandkumar, CEO of Bugworks Research, commented on her appointment: “Bugworks is pleased to welcome Dr. to welcome Renu Swarup to the Global Advisory Board. dr medical Swarup, an experienced geneticist, was formerly Secretary of the Department of Biotechnology, Ministry of Science & Technology, India. She has been a key contributor to shaping India’s biotechnology vision and strategy, including the COVID-19 vaccine initiatives. Under her inspiring leadership, the Biotechnology Industry Research Assistance Council (BIRAC) has ushered in a new wave of biotech SMEs and startups from which Bugworks has benefited early on. We look forward to working closely with Dr. Swarup, which will help us achieve our goal of providing equitable global access to Bugworks’ innovative products.”
dr Renu Swarup said about joining Bugworks Research: “I am pleased to be associated with Bugworks in my capacity as a Volunteer Advisor and member of the Global Advisory Board. Bugworks’ vision to address critical unmet health priorities such as AMR and cancer is of global importance. Their work on new broad-spectrum antibiotics and novel immuno-oncology small molecules targeting various solid cell tumors to make them affordable and accessible to humankind is of particular importance. The company fills a niche in its quest to provide patients, particularly those in LMICs, with access to cutting-edge therapies for infections and cancer.”
Founded in February 2014, Bugworks Research Inc. (Bugworks) is a clinical-stage biopharmaceutical company developing novel therapeutic compounds in the fields of anti-infectives and immuno-oncology (IO) utilizing innovative science in the fields of computational biology, pharmacology, structural biology and medicinal chemistry . Currently in a Phase 1 clinical trial, BWC0977 is targeting unmet need in severe hospital and community infections and bacterial threats. Their asset for IO is in late pre-clinical stage and targets multiple cancer types and is intended to be used either alone or in combination with immune checkpoint therapies.
Visit www.bugworksresearch.com for more information
Questions & contact:
Concept Public Relations
Archana Jain, email@example.com, +91 98455 41244
Aditi Nair, Aditi@conceptpr.com, +91 9071949810
View original content: